Clinical trials
Phase 3 Anemia, Sickle Cell trials in Oman
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 5 |
| Completed | 3 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 6 |
| Novo Nordisk A/S | 2 |
| Eli Lilly and Company | 1 |
| Forma Therapeutics, Inc. | 1 |
| Mast Therapeutics, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| Sanofi | 1 |
| Sultan Qaboos University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Sickle Cell | 14 |
| Vaso-Occlusive Crises | 6 |
| Hematologic Diseases | 5 |
| Sickle Cell Trait | 4 |
| Anemia | 1 |
| Anemia, Hemolytic | 1 |
| Genetic Diseases, Inborn | 1 |
| Hemoglobinopathies | 1 |
| Hemolysis | 1 |
| Thalassemia | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.